Cargando…

Identification and validation of a prognostic risk-scoring model based on the level of TIM-3 expression in acute myeloid leukemia

Acute myeloid leukemia (AML) is characterized by an unfavorable prognosis due to the presence of self-renewing leukemic stem cells (LSCs). The presence of T-cell immunoglobulin mucin-3 (TIM-3) on the surface of LSCs has been observed in various types of human AML, exerting an impact on the prognosti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Wanxue, Zheng, Shasha, Wang, Qi, Zhao, Na, Long, Zhiguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511414/ https://www.ncbi.nlm.nih.gov/pubmed/37730831 http://dx.doi.org/10.1038/s41598-023-42700-2

Ejemplares similares

The research progress of targeted therapy in acute myeloid leukemia based on bibliometric analysis
por: Huang, Wanxue, et al.
Publicado: (2022)

Upregulation of Tim‐3 is associated with poor prognosis in acute myeloid leukemia
por: Wu, Zhengwei, et al.
Publicado: (2022)

Identification and Validation of a Prognostic Risk-Scoring Model Based on Ferroptosis-Associated Cluster in Acute Myeloid Leukemia
por: Wang, Jinghua, et al.
Publicado: (2022)

One Stone, Two Birds: The Roles of Tim-3 in Acute Myeloid Leukemia
por: Wang, Zhiding, et al.
Publicado: (2021)

Development and Validation of a Novel RNA Sequencing–Based Prognostic Score for Acute Myeloid Leukemia
por: Wang, Mei, et al.
Publicado: (2018)

Identification the prognostic value of glutathione peroxidases expression levels in acute myeloid leukemia
por: Wei, Jie, et al.
Publicado: (2020)

Identification and Validation of STAT6 as a Prognostic and Predictive Biomarker in Acute Myeloid Leukemia
por: Liu, Wei, et al.
Publicado: (2020)

Identification of prognostic genes in the acute myeloid leukemia microenvironment
por: Huang, Shaoxin, et al.
Publicado: (2019)

New prognostic factors and scoring system for patients with acute myeloid leukemia
por: Kuang, Ye, et al.
Publicado: (2021)

Identification and validation of potential prognostic gene biomarkers for predicting survival in patients with acute myeloid leukemia
por: Huang, Rui, et al.
Publicado: (2017)

Identification and validation of inferior prognostic genes associated with immune signatures and chemotherapy outcome in acute myeloid leukemia
por: Wang, Jie, et al.
Publicado: (2021)

The Tim-3-galectin-9 Secretory Pathway is Involved in the Immune Escape of Human Acute Myeloid Leukemia Cells
por: Gonçalves Silva, Isabel, et al.
Publicado: (2017)

The correlation between Flt3-ITD mutation in dendritic cells with TIM-3 expression in acute myeloid leukemia
por: Shapoorian, Hooriyeh, et al.
Publicado: (2021)

P1375: VENETOCLAX MODULATES TIM-3 EXPRESSION ON CD8 T CELLS IN ACUTE MYELOID LEUKEMIA PATIENTS
por: Ocadlikova, Darina, et al.
Publicado: (2023)

TIM-3/Gal-9 interaction affects glucose and lipid metabolism in acute myeloid leukemia cell lines
por: Rezaei, Mahnaz, et al.
Publicado: (2023)

Identification and validation of obesity-related gene LEP methylation as a prognostic indicator in patients with acute myeloid leukemia
por: Zhang, Ting-juan, et al.
Publicado: (2021)

TIM3, a human acute myeloid leukemia stem cell marker, does not enrich for leukemia-initiating stem cells in B-cell acute lymphoblastic leukemia
por: Bueno, Clara, et al.
Publicado: (2023)

The immune receptor Tim-3 acts as a trafficker in a Tim-3/galectin-9 autocrine loop in human myeloid leukemia cells
por: Gonçalves Silva, Isabel, et al.
Publicado: (2016)

Real‐life challenges using personalized prognostic scoring systems in acute myeloid leukemia
por: Calleja, Anne, et al.
Publicado: (2022)

Validation of the Khorana score in acute myeloid leukemia patients: a single-institution experience
por: Mirza, Abu-Sayeef, et al.
Publicado: (2019)

TIM-3 signaling hijacks the canonical Wnt/β-catenin pathway to maintain cancer stemness in acute myeloid leukemia
por: Sakoda, Teppei, et al.
Publicado: (2023)

In Silico Methods for the Identification of Diagnostic and Favorable Prognostic Markers in Acute Myeloid Leukemia
por: Yılmaz, Hande, et al.
Publicado: (2021)

Identification of RHOBTB2 aberration as an independent prognostic indicator in acute myeloid leukemia
por: Liu, Peng, et al.
Publicado: (2021)

Identification and validation of a novel CD8+ T cell-associated prognostic model based on ferroptosis in acute myeloid leukemia
por: Jiang, Ge, et al.
Publicado: (2023)

Identification and validation of a 7-genes prognostic signature for adult acute myeloid leukemia based on aging-related genes
por: Ke, Peng, et al.
Publicado: (2023)

Construction and Validation of a Novel Ferroptosis-Related Prognostic Model for Acute Myeloid Leukemia
por: Song, Ying, et al.
Publicado: (2022)

Expression of immune check point gene TIM-3 in patients newly diagnosed with acute myeloid leukemia: Significance and impact on outcome
por: Kamal, Amany M., et al.
Publicado: (2021)

Development of Multidrug Resistance in Acute Myeloid Leukemia Is Associated with Alterations of the LPHN1/GAL-9/TIM-3 Signaling Pathway
por: Kocibalova, Zuzana, et al.
Publicado: (2021)

Mutations associated with a 17-gene leukemia stem cell score and the score’s prognostic relevance in the context of the European LeukemiaNet classification of acute myeloid leukemia
por: Bill, Marius, et al.
Publicado: (2020)

Identification and validation of signal recognition particle 14 as a prognostic biomarker predicting overall survival in patients with acute myeloid leukemia
por: Shi, Lingling, et al.
Publicado: (2021)

Risk Stratification of Chronic Myeloid Leukemia According to Different Prognostic Scores
por: Aijaz, Javeria, et al.
Publicado: (2020)

Identification of the 7-lncRNA Signature as a Prognostic Biomarker for Acute Myeloid Leukemia
por: Liu, Chun-yu, et al.
Publicado: (2021)

Identification of prognostic and driver gene mutations in acute myeloid leukemia by a bioinformatics analysis
por: Li, Lifang, et al.
Publicado: (2023)

Association of TIM-3 checkpoint receptor expression on T cells with treatment-free remission in chronic myeloid leukemia
por: Irani, Yazad D., et al.
Publicado: (2023)

Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia
por: Lachowiez, Curtis A., et al.
Publicado: (2022)

Identification of TLN1 as a prognostic biomarker to effect cell proliferation and differentiation in acute myeloid leukemia
por: Cui, Di, et al.
Publicado: (2022)

TIM-3/Gal-9 interaction induces IFNγ-dependent IDO1 expression in acute myeloid leukemia blast cells
por: Folgiero, Valentina, et al.
Publicado: (2015)

Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: potential impact of BMI-1, TIM-3 and CLL-1
por: Darwish, Noureldien H.E., et al.
Publicado: (2016)

Systematic Construction and Validation of an RNA-Binding Protein-Associated Prognostic Model for Acute Myeloid Leukemia
por: Luo, Hongwei, et al.
Publicado: (2021)

Development and validation of a novel circular RNA as an independent prognostic factor in acute myeloid leukemia
por: Wang, Jinghan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_674v24lgibqk1qmji9oojn9oeu